Smith & Nephew SNATS (NYSE:SNN) Sees Strong Trading Volume – What’s Next?

Smith & Nephew SNATS, Inc. (NYSE:SNN) saw unusually-strong trading volume on Monday . Approximately 2,182,169 shares were traded during trading, an increase of 82% from the previous session’s volume of 1,197,121 shares.The stock last traded at $28.85 and had previously closed at $28.97.

Wall Street Analysts Forecast Growth

Several analysts have recently issued reports on the company. Weiss Ratings downgraded Smith & Nephew SNATS from a “hold (c+)” rating to a “hold (c)” rating in a research report on Thursday, June 11th. Wall Street Zen upgraded Smith & Nephew SNATS from a “hold” rating to a “buy” rating in a research report on Monday, August 24th. Canaccord Genuity Group cut their target price on shares of Smith & Nephew SNATS from $32.00 to $30.00 and set a “hold” rating for the company in a research note on Monday, May 11th. Kepler Capital Markets lowered shares of Smith & Nephew SNATS from a “buy” rating to a “hold” rating in a report on Thursday, June 4th. Finally, The Goldman Sachs Group reiterated a “buy” rating on shares of Smith & Nephew SNATS in a report on Monday, May 25th. Two equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $30.93.

Smith & Nephew SNATS Trading Down 0.2%

The company has a 50-day moving average of $30.22 and a two-hundred day moving average of $31.66. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.11 and a current ratio of 2.14.

Smith & Nephew SNATS Dividend Announcement

The business also recently disclosed a dividend, which will be paid on Friday, November 6th. Stockholders of record on Friday, October 2nd will be issued a dividend of $0.312 per share. This represents a dividend yield of 205.0%. The ex-dividend date is Friday, October 2nd.

Institutional Investors Weigh In On Smith & Nephew SNATS

A number of institutional investors have recently bought and sold shares of the stock. Clearstead Trust LLC acquired a new position in Smith & Nephew SNATS during the second quarter worth approximately $25,000. Garner Asset Management Corp acquired a new position in shares of Smith & Nephew SNATS in the 4th quarter valued at $27,000. Arax Advisory Partners grew its stake in shares of Smith & Nephew SNATS by 142.6% during the 4th quarter. Arax Advisory Partners now owns 968 shares of the medical equipment provider’s stock valued at $32,000 after buying an additional 569 shares during the period. Advisors Asset Management Inc. acquired a new stake in shares of Smith & Nephew SNATS during the 4th quarter worth $36,000. Finally, Caitong International Asset Management Co. Ltd purchased a new position in shares of Smith & Nephew SNATS in the 3rd quarter worth $41,000. 25.64% of the stock is currently owned by hedge funds and other institutional investors.

Smith & Nephew SNATS Company Profile

Smith & Nephew plc is a global medical technology company specializing in the design, development and manufacture of advanced surgical devices, orthopaedic reconstruction implants, trauma and extremities products, sports medicine solutions and wound care therapies. Founded in 1856 in Hull, United Kingdom, the company has grown through both organic innovation and strategic acquisitions to offer a broad portfolio that addresses patient needs across joint replacement, minimally invasive surgery and wound healing.

In its orthopaedics business, Smith & Nephew provides hip and knee replacement systems, modular joint revision implants and biologic solutions for bone repair.